Please provide your email address to receive an email when new articles are posted on . High-risk African Americans offered a fruit and vegetable diet saw improved kidney outcomes and CVD risk factors ...
In April 2021, dapagliflozin (Farxiga) received a new indication from the US Food and Drug Administration (FDA) for slowing progression of chronic kidney disease (CKD) in people without any other ...
BOSTON, Mass., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company pioneering positive functional modulators (PFMs) that restore and enhance membrane ...
Collaboration aims to accelerate the development of treatments for chronic kidney disease (CKD) and other conditions Rectify has developed oral, small molecules that can potentially reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback